Medications

Reclassification recommendations for drug in 'magic mushrooms'

In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule ...

Psychology & Psychiatry

Child abuse could leave 'molecular scars' on its victims

Children who are abused might carry the imprint of that trauma in their cells—a biochemical marking that is detectable years later, according to new research from the University of British Columbia and Harvard University.

Medical research

Body's natural pain killers can be enhanced

Fentanyl, oxycodone, morphine—these substances are familiar to many as a source of both pain relief and the cause of a painful epidemic of addiction and death.

Health

Is vaping any healthier than smoking?

There's been plenty of scientific debate about whether vaping is safer than tobacco, and whether it may help some people stop smoking.

page 1 from 40